260 related articles for article (PubMed ID: 26006017)
1. TGFβ1 exacerbates blood-brain barrier permeability in a mouse model of hepatic encephalopathy via upregulation of MMP9 and downregulation of claudin-5.
McMillin MA; Frampton GA; Seiwell AP; Patel NS; Jacobs AN; DeMorrow S
Lab Invest; 2015 Aug; 95(8):903-13. PubMed ID: 26006017
[TBL] [Abstract][Full Text] [Related]
2. Gli1 activation and protection against hepatic encephalopathy is suppressed by circulating transforming growth factor β1 in mice.
McMillin M; Galindo C; Pae HY; Frampton G; Di Patre PL; Quinn M; Whittington E; DeMorrow S
J Hepatol; 2014 Dec; 61(6):1260-6. PubMed ID: 25046848
[TBL] [Abstract][Full Text] [Related]
3. Elevated circulating TGFβ1 during acute liver failure activates TGFβR2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy in mice.
McMillin M; Grant S; Frampton G; Petrescu AD; Williams E; Jefferson B; Thomas A; Brahmaroutu A; DeMorrow S
J Neuroinflammation; 2019 Apr; 16(1):69. PubMed ID: 30940161
[TBL] [Abstract][Full Text] [Related]
4. Blood-Brain Barrier Permeability Is Exacerbated in Experimental Model of Hepatic Encephalopathy via MMP-9 Activation and Downregulation of Tight Junction Proteins.
Dhanda S; Sandhir R
Mol Neurobiol; 2018 May; 55(5):3642-3659. PubMed ID: 28523565
[TBL] [Abstract][Full Text] [Related]
5. JAM-A Acts via C/EBP-α to Promote Claudin-5 Expression and Enhance Endothelial Barrier Function.
Kakogiannos N; Ferrari L; Giampietro C; Scalise AA; Maderna C; Ravà M; Taddei A; Lampugnani MG; Pisati F; Malinverno M; Martini E; Costa I; Lupia M; Cavallaro U; Beznoussenko GV; Mironov AA; Fernandes B; Rudini N; Dejana E; Giannotta M
Circ Res; 2020 Sep; 127(8):1056-1073. PubMed ID: 32673519
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin-1 Exacerbates Acute Liver Failure and Hepatic Encephalopathy Pathology in Mice by Activating Transforming Growth Factor β1.
Jefferson B; Ali M; Grant S; Frampton G; Ploof M; Andry S; DeMorrow S; McMillin M
Am J Pathol; 2020 Feb; 190(2):347-357. PubMed ID: 31734229
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 accelerates hypoxia-induced endothelial dysfunction in high-altitude cerebral edema.
Xue Y; Wang X; Wan B; Wang D; Li M; Cheng K; Luo Q; Wang D; Lu Y; Zhu L
Cell Commun Signal; 2022 Oct; 20(1):160. PubMed ID: 36253854
[TBL] [Abstract][Full Text] [Related]
8. RhoA/ROCK-2 Pathway Inhibition and Tight Junction Protein Upregulation by Catalpol Suppresses Lipopolysaccaride-Induced Disruption of Blood-Brain Barrier Permeability.
Feng S; Zou L; Wang H; He R; Liu K; Zhu H
Molecules; 2018 Sep; 23(9):. PubMed ID: 30227623
[TBL] [Abstract][Full Text] [Related]
9. ApoE-deficient promotes blood-brain barrier disruption in experimental autoimmune encephalomyelitis via alteration of MMP-9.
Zheng M; Wei J; Tang Y; Yang C; Wei Y; Yin X; Liu Q
J Mol Neurosci; 2014; 54(2):282-90. PubMed ID: 24788224
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis.
Blecharz KG; Haghikia A; Stasiolek M; Kruse N; Drenckhahn D; Gold R; Roewer N; Chan A; Förster CY
Mult Scler; 2010 Mar; 16(3):293-302. PubMed ID: 20203147
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products induce glomerular endothelial cell hyperpermeability by upregulating matrix metalloproteinase activity.
Luo P; Peng H; Li C; Ye Z; Tang H; Tang Y; Chen C; Lou T
Mol Med Rep; 2015 Jun; 11(6):4447-53. PubMed ID: 25634678
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid receptor, LPA
Masago K; Kihara Y; Yanagida K; Hamano F; Nakagawa S; Niwa M; Shimizu T
Biochem Biophys Res Commun; 2018 Jul; 501(4):1048-1054. PubMed ID: 29778535
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.
Feng S; Cen J; Huang Y; Shen H; Yao L; Wang Y; Chen Z
PLoS One; 2011; 6(8):e20599. PubMed ID: 21857898
[TBL] [Abstract][Full Text] [Related]
14. The Effect of TGF-β1 Reduced Functionality on the Expression of Selected Synaptic Proteins and Electrophysiological Parameters: Implications of Changes Observed in Acute Hepatic Encephalopathy.
Popek M; Bobula B; Orzeł-Gajowik K; Zielińska M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163004
[TBL] [Abstract][Full Text] [Related]
15. Ang-(1-7) exerts protective role in blood-brain barrier damage by the balance of TIMP-1/MMP-9.
Wu J; Zhao D; Wu S; Wang D
Eur J Pharmacol; 2015 Feb; 748():30-6. PubMed ID: 25523481
[TBL] [Abstract][Full Text] [Related]
16. Histone Deacetylase 3 Inhibition Decreases Cerebral Edema and Protects the Blood-Brain Barrier After Stroke.
Lu H; Ashiqueali R; Lin CI; Walchale A; Clendaniel V; Matheson R; Fisher M; Lo EH; Selim M; Shehadah A
Mol Neurobiol; 2023 Jan; 60(1):235-246. PubMed ID: 36258136
[TBL] [Abstract][Full Text] [Related]
17. Cilostazol attenuates ischemia-reperfusion-induced blood-brain barrier dysfunction enhanced by advanced glycation endproducts via transforming growth factor-β1 signaling.
Takeshita T; Nakagawa S; Tatsumi R; So G; Hayashi K; Tanaka K; Deli MA; Nagata I; Niwa M
Mol Cell Neurosci; 2014 May; 60():1-9. PubMed ID: 24472843
[TBL] [Abstract][Full Text] [Related]
18. Absence of MCP-induced Protein 1 Enhances Blood-Brain Barrier Breakdown after Experimental Stroke in Mice.
Jin Z; Liang J; Li J; Kolattukudy PE
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261992
[TBL] [Abstract][Full Text] [Related]
19. Site-specific opening of the blood-brain barrier by extracellular histones.
Villalba N; Baby S; Cha BJ; Yuan SY
J Neuroinflammation; 2020 Sep; 17(1):281. PubMed ID: 32962721
[TBL] [Abstract][Full Text] [Related]
20. Lowering of brain endothelial cell barrier function by exposure to 4'-iodo-α-pyrrolidinononanophenone.
Sakai Y; Taguchi M; Morikawa Y; Suenami K; Yanase E; Takayama T; Ikari A; Matsunaga T
Chem Biol Interact; 2022 Sep; 364():110052. PubMed ID: 35872046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
